---
title: "Cyclerion Therapeutics (CYCN.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/CYCN.US/norm.md"
symbol: "CYCN.US"
name: "Cyclerion Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/CYCN.US.md"
datetime: "2026-03-07T04:48:32.655Z"
locales:
  - [en](https://longbridge.com/en/quote/CYCN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CYCN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CYCN.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/CYCN.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/CYCN.US/norm.md)


# Cyclerion Therapeutics (CYCN.US) — 財務報表

## 損益表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.3026 | -0.1055 | -0.5591 | 0.2085 | -0.2862 |
| ROE | -43.12% | -14.94% | -64.84% | 24.87% | -34.06% |
| 營業收入 | 875000.00 | 93000.00 | 81000.00 | 1.81M | 194000.00 |
| 凈利潤 | -976000.00 | -324000.00 | -1.43M | 530000.00 | -723000.00 |
| 營業利潤 | -1.01M | -1.67M | -1.46M | 502000.00 | -1.13M |
| 毛利率 | 60.23% | 39.78% | 55.56% | 112.74% | 58.25% |
| 凈利率 | -111.54% | -348.39% | -1764.20% | 29.35% | -372.68% |
| 利潤含金量 | - | - | - | 139.44% | - |

## 資產負債表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 10.41M | 9.37M | 9.85M | 9.57M | 8.90M |
| 權益乘數 | 1.09 | 1.09 | 1.12 | 1.08 | 1.09 |
| 每股凈資產 | 2.58 | 2.79 | 2.87 | 3.48 | 3.24 |
| 資產周轉率 | 0.2957 | 0.2237 | 0.1962 | 0.1743 | 0.0161 |
| 現金及短投 | 4.57M | 3.01M | 3.64M | 3.23M | 2.87M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | - | - | - | - | - |
| 凈債務 | -4.57M | -3.01M | -3.64M | -3.23M | -2.87M |

## 現金流量表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -264000.00 | -503000.00 | -968000.00 | 360000.00 | -1.72M |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 1.83M | -130000.00 | 1.38M | - | - |
| 自由現金流 | 83250.00 | -1.35M | -319625.00 | 143750.00 | -1.70M |
| 現金流充裕率 | - | - | - | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | - | - | - | - |